BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2318 related articles for article (PubMed ID: 20574901)

  • 1. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual tissues in toxicology.
    Shah I; Wambaugh J
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):314-28. PubMed ID: 20574905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME; Krewski D
    Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of toxicity testing.
    Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity testing in the 21st century: how will it affect risk assessment?
    Rhomberg LR
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U.S. Environmental Protection Agency strategic plan for evaluating the toxicity of chemicals.
    Firestone M; Kavlock R; Zenick H; Kramer M;
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):139-62. PubMed ID: 20574895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SysBioMed report: advancing systems biology for medical applications.
    Wolkenhauer O; Fell D; De Meyts P; Blüthgen N; Herzel H; Le Novère N; Höfer T; Schürrle K; van Leeuwen I
    IET Syst Biol; 2009 May; 3(3):131-6. PubMed ID: 19449974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward computational systems biology.
    You L
    Cell Biochem Biophys; 2004; 40(2):167-84. PubMed ID: 15054221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity testing in the 21st century: implications for human health risk assessment.
    Krewski D; Andersen ME; Mantus E; Zeise L
    Risk Anal; 2009 Apr; 29(4):474-9. PubMed ID: 19144067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein biomarkers for in vitro testing of toxicology.
    Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
    Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic modeling and analysis of cancer cellular network motifs.
    Cloutier M; Wang E
    Integr Biol (Camb); 2011 Jul; 3(7):724-32. PubMed ID: 21674097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing the National Academy's Vision and Strategy for Toxicity Testing: opportunities and challenges under the U.S. Toxic Substances Control Act.
    Locke PA; Bruce Myers D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):376-84. PubMed ID: 20574909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology and addiction.
    Tretter F; Gebicke-Haerter PJ; Albus M; an der Heiden U; Schwegler H
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S11-31. PubMed ID: 19434548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically relevant exposure science for 21st century toxicity testing.
    Hubal EA
    Toxicol Sci; 2009 Oct; 111(2):226-32. PubMed ID: 19602574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].
    Pezard L; Nandrino JL
    Encephale; 2001; 27(3):260-8. PubMed ID: 11488256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure science and the U.S. EPA National Center for Computational Toxicology.
    Cohen Hubal EA; Richard AM; Shah I; Gallagher J; Kavlock R; Blancato J; Edwards SW
    J Expo Sci Environ Epidemiol; 2010 May; 20(3):231-6. PubMed ID: 18985077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.